Satori Raises $15M for AD Platform, Looks to File IND
By Marie Powers
Friday, February 24, 2012
Privately held Satori Pharmaceuticals Inc. raised $15 million in an inside round from existing investors as it prepares to move its Alzheimer's disease (AD) technology into the clinic.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.